These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14674677)

  • 1. Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel.
    Stanat SJ; Carlton CG; Crumb WJ; Agrawal KC; Clarkson CW
    Mol Cell Biochem; 2003 Dec; 254(1-2):1-7. PubMed ID: 14674677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics.
    Volberg WA; Koci BJ; Su W; Lin J; Zhou J
    J Pharmacol Exp Ther; 2002 Jul; 302(1):320-7. PubMed ID: 12065733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of erythromycin on potassium currents in rat ventricular myocytes in comparison with disopyramide.
    Hanada E; Ohtani H; Hirota M; Uemura N; Nakaya H; Kotaki H; Sato H; Yamada Y; Iga T
    J Pharm Pharmacol; 2003 Jul; 55(7):995-1002. PubMed ID: 12906757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoridazine: an open-channel blocker of human ether-a-go-go-related gene K+ channel.
    Su Z; Martin R; Cox BF; Gintant G
    J Mol Cell Cardiol; 2004 Jan; 36(1):151-60. PubMed ID: 14734057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-malarial drug halofantrine and its metabolite N-desbutylhalofantrine block HERG potassium channels.
    Mbai M; Rajamani S; January CT
    Cardiovasc Res; 2002 Sep; 55(4):799-805. PubMed ID: 12176129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of HERG and Kv1.5 by ketoconazole.
    Dumaine R; Roy ML; Brown AM
    J Pharmacol Exp Ther; 1998 Aug; 286(2):727-35. PubMed ID: 9694927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of HERG potassium channels by extracellular magnesium and quinidine.
    Po SS; Wang DW; Yang IC; Johnson JP; Nie L; Bennett PB
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):181-5. PubMed ID: 10028924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells.
    Traebert M; Dumotier B; Meister L; Hoffmann P; Dominguez-Estevez M; Suter W
    Eur J Pharmacol; 2004 Jan; 484(1):41-8. PubMed ID: 14729380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current.
    Witchel HJ; Hancox JC
    Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):753-66. PubMed ID: 11022966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.
    Paul AA; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1243-50. PubMed ID: 11162661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG.
    Kang J; Wang L; Chen XL; Triggle DJ; Rampe D
    Mol Pharmacol; 2001 Jan; 59(1):122-6. PubMed ID: 11125032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
    Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
    Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.
    Zhou Z; Gong Q; Ye B; Fan Z; Makielski JC; Robertson GA; January CT
    Biophys J; 1998 Jan; 74(1):230-41. PubMed ID: 9449325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Block of HERG current expressed in HEK293 cells by the Na+-channel blocker cibenzoline.
    Hiramatsu M; Wu LM; Hirano Y; Kawano S; Furukawa T; Hiraoka M
    Heart Vessels; 2004 May; 19(3):137-43. PubMed ID: 15168062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o.
    Diaz GJ; Daniell K; Leitza ST; Martin RL; Su Z; McDermott JS; Cox BF; Gintant GA
    J Pharmacol Toxicol Methods; 2004; 50(3):187-99. PubMed ID: 15519905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG.
    Rampe D; Murawsky MK; Grau J; Lewis EW
    J Pharmacol Exp Ther; 1998 Aug; 286(2):788-93. PubMed ID: 9694935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels.
    Kuryshev YA; Brown AM; Wang L; Benedict CR; Rampe D
    J Pharmacol Exp Ther; 2000 Nov; 295(2):614-20. PubMed ID: 11046096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
    Rampe D; Roy ML; Dennis A; Brown AM
    FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Block of HERG-carried K+ currents by the new repolarization delaying agent H 345/52.
    Amos GJ; Jacobson I; Duker G; Carlsson L
    J Cardiovasc Electrophysiol; 2003 Jun; 14(6):651-8. PubMed ID: 12875428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG.
    Kang J; Chen XL; Wang L; Rampe D
    J Pharmacol Exp Ther; 2001 Oct; 299(1):290-6. PubMed ID: 11561091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.